#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia chromosome positive Osteomyelitis Osteosarcoma recurrent Pleomorphic liposarcoma Small cell lung cancer Primary immunodeficiency syndrome Haemophilia A without inhibitors Krabbe's disease Hypoxic-ischaemic encephalopathy Astrocytoma Renal cell carcinoma Neuroendocrine tumour Ischaemic stroke Small cell lung cancer recurrent Cardiac failure acute More trials…

    Learn about Rare Diseases

    Turner’s syndrome – Life with Disease Ewing’s sarcoma recurrent – Basic Information Burkitt’s lymphoma – Trials in Disease Mantle cell lymphoma stage II – Basic Information Aicardi-Goutieres syndrome – Trials in Disease Haemophilia B with anti factor IX – Life with Disease Cholangitis sclerosing – Diagnostics Burkitt’s lymphoma – Basic Information Paroxysmal nocturnal haemoglobinuria Alternating hemiplegia of childhood – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Risankizumab Enfuvirtide Copper (64Cu) Chloride Calcium Pantothenate Bp Iptacopan Hydrochloride Lorazepam Clofutriben Calcium Chloride Hexahydrate Methotrexate Levocabastine Hydrochloride Asundexian DESMOPRESSIN ACETATE Gallium (68Ga) Omp10 TIL CELLS Ivabradine Ipratropium Bromide Iph5201 Trifluridine 7-Ethyl-10-Hydroxycamptothecin More therapies…

    Learn about Your Condition

    Dermatitis Lung neoplasm malignant Cancer pain Cachexia Myxofibrosarcoma Postoperative delirium Mitochondrial DNA depletion Bipolar disorder Asymptomatic HIV infection Bacteraemia Retinopathy proliferative Lennox-Gastaut syndrome Subdural haematoma Burkitt's lymphoma Hepatoblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A Study of Encoberminogene Rezmadenovec Gene Therapy for Patients with Refractory Angina Due to Coronary Artery Disease

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • 13N-AMMONIA
    Belgium Germany Hungary The Netherlands Poland

  • Testing Antibiotic Treatment Strategies for Patients with Bladder Bacteria Without Symptoms Receiving Botulinum Toxin A Bladder Injections

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefixime
    • Ofloxacin
    • Nitrofurantoin
    France

  • A Study Testing How Well LTG-001 Works and Its Safety in Patients with Knee Osteoarthritis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • LTG-001
    Denmark

  • A Study of Intranasal Dexmedetomidine for Sedation in Children Undergoing Non-Invasive Radiological Procedures

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Dexmedetomidine
    Belgium

  • A Study of Isosorbide Mononitrate for Patients with Normal Tension Glaucoma to Improve Blood Flow to the Optic Nerve

    Not yet recruiting

    3 1 1
    Finland

  • A Study of Candesartan to Prevent Chronic Cluster Headache Attacks in Adults with Chronic Cluster Headache

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Candesartan
    Denmark Norway
Previous Page
1 … 774 775 776 777 778 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!